Objective-We tested the hypothesis that short telomere length is associated with increased risk of myocardial infarction, ischemic heart disease, and early death.
T elomeres are protective chromosomal caps at the linear ends of chromosomes consisting of a variable number of TTAGGG repeats. 1 Telomeres shorten with each cell cycle in most cells and therefore reflect organism aging at a cellular level. 1, 2 Accordingly, telomere length decreases with increasing age 3, 4 but also with male sex, smoking, adiposity, oxidative stress, UV irradiation, and low socioeconomic status. 2, 3, [5] [6] [7] It has therefore been a matter of speculation whether short telomere length is associated with increased risk of cardiovascular disease and early death. 5,8 -10 Previous studies of telomere length and human disease have been limited by cumbersome techniques mainly allowing low-throughput measurements. 11 Furthermore, the majority of studies so far have mainly been smaller case-control studies rather than large prospective studies of unselected individuals from the general population. 12 Accordingly, there is a need for large studies of the general population with extended follow-up, with telomere length measured reliably with a high-throughput method to examine the influence of short telomere length on cardiovascular disease and early death.
We tested the hypothesis that short telomere length is associated with increased risk of myocardial infarction, ischemic heart disease, and early death. For this reason, we developed a high-throughput real-time polymerase chain reaction assay calibrated to measure absolute telomere length. Subsequently, we measured 19 838 individuals from 2 prospective studies of the Danish general population from the Copenhagen City Heart Study and the Copenhagen General Population Study, followed for up to 19 years.
Methods

Study Design
The Copenhagen City Heart Study is a population-based prospective study initiated in 1976 to 1978. 13, 14 Participants aged 20 years or above were randomly invited from the Central Population Register and reexamined in 1981 to 1983, 1991 to 1994, and 2001 to 2003, with younger participants added at each reexamination. Whole blood samples from the last 2 examinations were used for DNA isolation. We included 9765 participants with available DNA samples.
The Copenhagen General Population Study is a parallel population-based prospective study initiated in 2003 and still recruiting. 15 Participant selection and data collection were similar to that in the Copenhagen City Heart Study. We included the first 10 073 participants with available DNA samples.
All participants in both studies were white and of Danish descent. There was no overlap of individuals between the 2 studies, thus permitting independent confirmation of findings in each study.
Covariates
Before examinations, participants filled in self-administered questionnaires concerning present and past lifestyle and health status. This was completed on the day of examination, before physical examination, blood sampling, and measurement of cardiovascular risk factors. The following covariates were obtained or measured [13] [14] [15] : age at examination (years), gender (male/female), total cholesterol levels (mmol/L), triglyceride levels (mmol/L), high-density lipoprotein cholesterol levels (mmol/L), high sensitivity C-reactive protein levels (mg/L), use of lipid lowering therapy (no/yes), body mass index (measured weight in kilograms divided by squared measured height in meters), hypertension (no/yes) (yes if participants had systolic blood pressure Ͼ140 mm Hg, diastolic blood pressure Ͼ90 mm Hg, or reported use of antihypertensive medication), diabetes mellitus (no/yes) (yes if nonfasting blood glucose was Ͼ11 mmol/L or if the participant reported having diabetes mellitus or using antidiabetic medication), current smoking (no/yes), heavy alcohol intake (no/yes) (yes if female and male participants reported a weekly alcohol intake above 87.5 and 175 g, respectively), physical inactivity (no/yes) (yes if participants reported Ͻ4 hours of leisure time physical activity per week), postmenopausal (no/yes) (yes if women reported being postmenopausal or using hormone replacement therapy or were aged 60 years or above), and use of hormone replacement therapy (yes if women reported use of hormone replacement therapy).
End Points
Using the unique Danish personal identification numbers, date of death was obtained from the Danish Civil Registration System, whereas diagnoses and dates of myocardial infarction and ischemic heart disease were obtained from the national Danish Patient Registry and the national Danish Cause of Death Registry. Diagnoses were classified according to the World Health Organization International Classification of Disease (ICD), 8th revision (ICD-8 codes 410 for myocardial infarction and 410 -414 for ischemic heart disease) until 1993, and ICD 10th revision thereafter (ICD-10 codes I21-I22 for myocardial infarction and I20 -I25 for ischemic heart disease). Follow-up was 100% complete; that is, we did not lose track of even a single individual.
Telomere Length
We measured telomere length in DNA from leukocytes in peripheral blood, a measurement highly correlated with telomere length in cells from other tissues. 8 -10 Telomere length was measured on a CFX384 real-time polymerase chain reaction detection system (Bio-Rad Laboratories), using a modified monochrome multiplex quantitative polymerase chain reaction method. 16, 17 Failed samples were measured a second time, and a third if they failed again. Therefore, valid measurements of telomere lengths were available for more than 99.9% of participants. The interassay coefficient of variation of the internal NTERA-2 control was 2% for Ct values at mean values of 17.9 cycles for the telomere assay and 9% for absolute telomere length at the mean level of 2534 base pairs. For a complete 
Statistical Analyses
We used the statistical software package STATA version 11.1 for analysis (StataCorp, College Station, TX). Two-sided PϽ0.05 was significant. We used Cox proportional hazard regression with lefttruncated age as the time scale to calculate hazard ratios, which means that the analyses automatically adjusted for age; when we mention in this article that analyses were adjusted for age, we refer to this automatic age adjustment. For all end points, follow-up began at the day of blood sampling. Participants diagnosed with an end point before study entry were excluded from analyses, which is why the number of participants varies between end points. For all end points, follow-up ended at first incident diagnosis, death, emigration, or August 17, 2010, whichever came first. The maximum and median follow-ups were 19 and 17 years, respectively, in the Copenhagen City Heart Study and 7 and 6 years in the Copenhagen General Population Study. Cox regressions were adjusted for age, gender, and study, or multifactorially adjusted for age, gender, study, levels of total cholesterol, triglycerides, high-density lipoprotein cholesterol, C-reactive protein, use of lipid lowering therapy, body mass index, hypertension, diabetes mellitus, current smoking, heavy alcohol intake, physical inactivity, postmenopausal status (women only), and use of hormone replacement therapy (women only). Information on covariates was more than 99% complete, and missing continuous covariates were imputed based on age and gender, whereas missing categorical values were assigned to a missing category. For the Copenhagen City Heart Study, data from the 1991 to 1994 and 2001 to 2003 examinations were used as time-dependent covariates for multifactorial adjustment. The proportional hazard assumption was assessed visually by plotting Ϫln(Ϫln(survival)) versus ln(age): no major violations were observed. For trend test, participants were categorized according to decreasing telomere length in study-specific quartiles and deciles coded 1 to 4 and 1 to 10, respectively, with the first quartile or decile consisting of participants with the longest telomeres. Interaction between telomere length and each of the covariates adjusted for in the models were investigated by including a 2-factor interaction term and testing them for significance using a Wald test.
Ethical Considerations
The Danish Data Protection Agency, Herlev Hospital, Copenhagen University Hospital, and a local Danish ethical committee approved the studies (KF100.2039/91 and H-KF01-144/01). All participants gave written informed consent.
Results
Telomere Length and Age
Telomere length decreased linearly with increasing age in women and men in both studies of the general population (Pϭ7ϫ10 Ϫ74 to Pϭ3ϫ10 Ϫ125 ) ( Figure 1 ); R 2 between age and telomere length ranged from 6% to 11%. Telomere length decreased by 20 base pairs per year of increase in age in the Copenhagen City Heart Study and by 14.5 base pairs in the Copenhagen General Population Study. In addition, as shown in Table 1 , decreasing telomere length was also associated with male gender, increasing levels of total cholesterol, triglycerides, and C-reactive protein, decreasing levels of high-density lipoprotein cholesterol, use of lipid lowering therapy, increasing body mass index, hypertension, diabetes mellitus, current smoking, decreasing heavy alcohol intake, physical inactivity, and for women only postmenopausal status and use of hormone replacement therapy.
Telomere Length and Myocardial Infarction
During follow-up, 929 participants developed myocardial infarction in the 2 studies combined. Per 1000 -base pair decrease in telomere length, the multifactorially adjusted hazard ratio of myocardial infarction was 1.10 (95% CI 1.01-1.19) ( Table 2 ). Similar hazard ratios were found in an age-, gender-, and study-adjusted model; in each study alone; and in each gender separately. When stratifying in subgroups of age, gender, and biochemical and lifestyle cardiovascular risk factors, we found no evidence of interaction between Total cholesterol, mmol/L 5.8 (5.0-6.7) 5.9 (5.0-6.9) 6.0 (5.3-7.0) 6.1 (5.3-6.9) 1.0ϫ10 Ϫ17 5.6 (4.9-6.3) 5.6 (4.9-6.4) 5.7 (4.9-6.4) 5.7 (5.0-6.4) 0.001 these factors and decreasing telomere length on risk of myocardial infarction after Bonferroni correction (Figure 2 ; required probability value Ͻ0.05/15ϭ0.003). When divided into study-specific quartiles and deciles of telomere length in the 2 studies combined, we found a multifactorially adjusted hazard ratio for myocardial infarction of 1.18 (0.97-1.43) in the quartile and 1.49 (1.07-2.07) in the decile with the shortest telomeres versus participants in the quartile and decile, respectively, with the longest telomeres (trend tests across quartiles and deciles were Pϭ0.01 and Pϭ0.002; Figure 3 ).
Telomere Length and Ischemic Heart Disease
During follow-up, 2038 participants developed ischemic heart disease in the 2 studies combined. Per 1000 -base pair decrease in telomere length, the multifactorially adjusted hazard ratio of ischemic heart disease was 1.06 (95% CI 1.00 -1.11) ( Table 2 ). Similar hazard ratios were found in an age-, gender-, and study-adjusted model; in each study alone; and in each gender separately. When stratifying in subgroups of age, gender, and biochemical and lifestyle cardiovascular risk factors, we found no evidence of interaction between these factors and decreasing telomere length on risk of ischemic heart disease after Bonferroni correction ( Figure 2 ). When divided into quartiles and deciles of telomere length in the 2 studies combined, we found a multifactorially adjusted hazard ratio for ischemic heart disease of 1.06 (0.93-1.20) in the quartile and 1.24(1.01-1.53) and the decile with the shortest telomeres versus participants in the quartile and decile, respectively, with the longest telomeres (trend tests across quartiles and deciles were Pϭ0.22 and Pϭ0.03; Figure 3 ).
Telomere Length and Early Death
During follow-up, 4342 participants died in the 2 studies combined. Per 1000 -base pair decrease in telomere length, the multifactorially adjusted hazard ratio of early death was 1.09 (95% CI 1.05-1.13) ( Table 2 ). Similar hazard ratios were found in an age-, gender-, and study-adjusted model; in each study alone; and in each gender separately. When stratifying in subgroups of age, gender, and biochemical and lifestyle cardiovascular risk factors, we found no evidence of interaction between these factors and decreasing telomere length on risk of early death after Bonferroni correction ( Figure 2 ). When divided into quartiles and deciles of telomere length in the 2 studies combined, we found a multifactorially adjusted hazard ratio for early death of 1.18 (1.08 -1.29) in the quartile and 1.25 (1.07-1.46) in the decile with the shortest telomeres versus participants in the quartile and decile, respectively, with the longest telomeres (trend tests across quartiles and deciles were Pϭ4ϫ10 Ϫ4 and Pϭ6ϫ10 Ϫ5 ; Figure 3 ).
Discussion
After measuring telomere length using a high-throughput real-time polymerase chain reaction method in 19 838 individuals from the general population followed for up to 19 years, we observed that short telomere length was associated only modestly with increased risk of myocardial infarction, ischemic heart disease, and early death. We cannot exclude that these modest risk estimates could be explained by residual undetected confounding. The mechanism behind these findings could be that short telomere length is a marker of a systemic degenerative phenotype arising after years of exposure to cardiovascular risk factors, causing cellular damage and resulting in an increasing frequency of tissue mitosis and thereby shorter telomere length. 18 A systemic degenerative phenotype could then lead to the observed increased risk of myocardial infarction, ischemic heart disease, and early death. *Adjusted for age, gender, study, cholesterol, triglycerides, high-density lipoprotein cholesterol, C-reactive protein, use of lipid lowering therapy, body mass index, hypertension, diabetes mellitus, smoking, heavy alcohol intake, and physical inactivity; in women, also adjusted for postmenopausal status and hormone replacement therapy.
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We confirmed previous findings of a strong linear correlation between decreasing telomere length and increasing age 4,7,19 -25 demonstrating the validity of our high-throughput assay. In our studies of the general population, telomere length decreased by 14.5 to 20 base pairs per year. This is similar to the finding in previous reports of 14 to 29 base pairs lost per year, 3, 20, 23 but less than that in other reports of up to 7 base pairs lost per year. [22] [23] [24] 26, 28 These study differences may reflect interpopulation variation, 29 or they may be a result of interassay variation because some former assays included subtelomeric regions. 30 For myocardial infarction, the present observation of association between decreasing telomere length and increased risk is in accordance with previous studies, 4, 20, 27, 31 all smaller than the present one. Following 19 284 individuals prospectively for up to 19 years, we detected 929 incident myocardial infarctions and a hazard ratio for myocardial infarction of 1.18 (95% CI 0.97-1.43) for individuals in the shortest versus longest telomere quartile, whereas the Bruneck Study, a prospective study of 800 individuals followed for 10 years, observed 43 incident myocardial infarctions and a hazard ratio of 3.58 (1.32-9.70) for individuals in the shortest versus the longest telomere tertile. 4 Also, the Cardiovascular Health Study, a prospective study of 388 individuals followed for 7 years, reported 36 incident myocardial infarctions and a hazard ratio for myocardial infarction of 1.55 (0.85-2.83) per 1000 -base pair decrease in telomere length, 27 whereas our comparable hazard ratio was 1 .10 (1.01-1.19 ). Finally, a case-control study from Leicester of 203 cases and 180 controls reported an odds ratio for myocardial infarction of 2.79 (1.53-5.11) for individuals in the shortest versus the longest telomere length quartile. 20 10 (1.01-1.19)  1.06 (1.00-1.11)  1.09 (1.05-1.13 ) Age p = 0.06 p = 0.37 p = 0.73 Less than 57 years 0. 
Hazard ratio (95%CI)
Hazard ratio (95%CI) Hazard ratio (95%CI) y ( ) ( ) ( ) Gender p = 0.45 p = 0.02 p = 0.50 Women 1.13 (1.00-1.29)  1.02 (0.95-1.10)  1.08 (1.02-1.14)  Men  1.08 (0.97-1.20)  1.09 (1.01-1.18))  1.10 (1.04-1.16 ) Cholesterol p = 0.53 p = 0.02 p = 0.05 Less than 6 mmol/L 1.09 (0.97-1.22)  1.31 (1.10-1.57)  1.22 (1.08-1 .37) 6 mmol/L or above 1.13 (0.84-1.50)  1.04 (0.98-1.10)  1.08 (1.03-1.12 ) Triglycerides p = 0.15 p = 0.16 p = 0.47 Less than 1.8 mmol/L 1.17 (1.03-1.33)  1.10 (1.02-1.19)  1.09 (1.04-1.15 
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and present studies all support that decreasing telomere length is associated with increased risk of myocardial infarction, whereas the present study, with the most statistical power, suggests that the magnitude of the risk estimate is more modest than originally thought. For risk of ischemic heart disease, the present study detected 2038 events and a hazard ratio of 1.06 (0.93-1.20) for individuals in the shortest versus longest telomere quartiles, a modest effect size compared with that in a previous study. 32 Here, in the West of Scotland Primary Prevention Study, a nested case-control study of 484 cases and 1058 controls, an odds ratio for ischemic heart disease of 1.44 (1.10 -1.90) was observed for individuals in the shortest versus the longest telomere tertile. 32 However, as participants in that study were randomly assigned to treatment with statins or placebo, these results not be directly comparable to those of our study.
For risk of early death, our observed 4342 deaths and a hazard ratio of 1.09 (1.05-1.13) per 1000 -base pair decrease in telomere length is similar to that of 1.22 (0.91-1.63) observed in the Cardiovascular Health Study, a prospective study of 419 individuals followed for 7 years with 156 deaths. 27 However, a prospective study of 143 individuals aged 60 years or older followed for a maximum of 20 years, reported 101 deaths and a 1.86 (1.22-2.83)-fold mortality rate for individuals in the shortest versus the longest half of telomere length. 33 In contrast to our findings and that of the other reports mentioned above, 27, 33 a prospective study of 812 individuals aged 73 years or older observed 412 deaths but no association between telomere length and overall survival. 34 Taken together, the combined evidence supports that short telomere length is associated with a modest increased risk of early death.
Strengths of the present study include the large study size of 19 838 participants from the general population followed prospectively for up to 19 years. Second, telomere length was measured with a new, high-throughput assay, validated through inverse association with age. Third, telomere length was measured on more than 99.9% of available participants because of several rounds or reruns. Fourth, because of the national Danish Civil Registration System and the national Danish Patient Registry, we had complete information on incident myocardial infarction, ischemic heart disease, and death during follow-up. Fifth, using 2 independent studies, we were able to confirm findings across studies, minimizing the risk of chance findings. Sixth, we determined the absolute telomere length of our calibrator to 5290 base pairs, which was comparable to previous reports for this cell line of 5360 and 6500 base pairs. 35, 36 Limitations of the present study include that we examined risk of cardiovascular disease and early death in whites only, and our results may therefore not necessarily be applicable to other ethnicities. Also, we measured telomere length in leukocytes from peripheral blood only, and not in all cell types in the body; however, leukocyte telomere length is highly correlated with that in cells from other tissues. 5,8 -10 Finally, there is a question of whether a variable such as telomere length that is closely related with age can be a strong "age-independent" determinant of another variable, such as morbidity and mortality. However, although decreasing telomere length was associated with increasing age, age explained only 6% to 11% of the variation in telomere length, and we adjusted for age in all our analyses.
In conclusion, short telomere length is associated only modestly with increased risk of myocardial infarction, ischemic heart disease, and early death.
